These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12750467)

  • 1. Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate.
    Winter-Vann AM; Kamen BA; Bergo MO; Young SG; Melnyk S; James SJ; Casey PJ
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6529-34. PubMed ID: 12750467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprenylcysteine carboxyl methyltransferase activity modulates endothelial cell apoptosis.
    Kramer K; Harrington EO; Lu Q; Bellas R; Newton J; Sheahan KL; Rounds S
    Mol Biol Cell; 2003 Mar; 14(3):848-57. PubMed ID: 12631708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf.
    Bergo MO; Gavino BJ; Hong C; Beigneux AP; McMahon M; Casey PJ; Young SG
    J Clin Invest; 2004 Feb; 113(4):539-50. PubMed ID: 14966563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells.
    Bergo MO; Leung GK; Ambroziak P; Otto JC; Casey PJ; Young SG
    J Biol Chem; 2000 Jun; 275(23):17605-10. PubMed ID: 10747846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function.
    Svensson AW; Casey PJ; Young SG; Bergo MO
    Methods Enzymol; 2006; 407():144-59. PubMed ID: 16757321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprenylcysteine Carboxyl Methyltransferase and Its Substrate Ras Are Critical Players Regulating TLR-Mediated Inflammatory Responses.
    Yang WS; Kim HG; Kim E; Han SY; Aziz N; Yi YS; Kim S; Lee Y; Yoo BC; Han JW; Parameswaran N; Kim JH; Cho JY
    Cells; 2020 May; 9(5):. PubMed ID: 32422978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
    Pan Q; Liu R; Banu H; Ma L; Li H
    Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprenylcysteine carboxyl methyltransferase modulates endothelial monolayer permeability: involvement of RhoA carboxyl methylation.
    Lu Q; Harrington EO; Hai CM; Newton J; Garber M; Hirase T; Rounds S
    Circ Res; 2004 Feb; 94(3):306-15. PubMed ID: 14699010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
    Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation.
    Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
    Zhu Y; Hu Q; Li H
    Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.
    Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY
    Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine dialdehyde suppresses MMP-9-mediated invasion of cancer cells by blocking the Ras/Raf-1/ERK/AP-1 signaling pathway.
    Kim JH; Kim JH; Kim SC; Yi YS; Yang WS; Yang Y; Kim HG; Lee JY; Kim KH; Yoo BC; Hong S; Cho JY
    Biochem Pharmacol; 2013 Nov; 86(9):1285-300. PubMed ID: 23994169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
    Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
    Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprenylcysteine carboxyl methyltransferase promotes the progression of tongue squamous cell carcinoma via the K-Ras and RhoA signaling pathways.
    Wang S; Wang W; Zhang S; Yang F; Qiu J; Guo Q; Zheng J; Chen Z
    Arch Oral Biol; 2022 Feb; 134():105320. PubMed ID: 34875442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the integral membrane methyltransferase isoprenylcysteine carboxyl methyltransferase (ICMT) reveals potential substrate binding sites.
    Diver MM; Long SB
    J Biol Chem; 2014 Sep; 289(38):26007-26020. PubMed ID: 25059662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of Isoprenylcysteine Carboxyl Methyltransferase (ICMT) Leads to Progressive Loss of Photoreceptor Function.
    Christiansen JR; Pendse ND; Kolandaivelu S; Bergo MO; Young SG; Ramamurthy V
    J Neurosci; 2016 May; 36(18):5107-14. PubMed ID: 27147662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane.
    Ahearn IM; Court HR; Siddiqui F; Abankwa D; Philips MR
    Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33579760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
    Cushman I; Casey PJ
    J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprenylcysteine carboxyl methyltransferase is critical for glioblastoma growth and survival by activating Ras/Raf/Mek/Erk.
    Wan W; Xiao W; Pan W; Chen L; Liu Z; Xu J
    Cancer Chemother Pharmacol; 2022 Mar; 89(3):401-411. PubMed ID: 35171349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.